Exemestane (Aromasin) — Dosing, Cycles, Half-Life & Side Effects

Exemestane (Aromasin) is an aromatase inhibitor with a half-life of 8.9 hours in men (Mauras 2003, PMID: 14671195); 27 hours is the postmenopausal-women figure on the FDA Aromasin label and remains in the engine PK block (pk.halfLifeHours) pending a separate golden-file review.. Irreversible (suicide) aromatase inhibitor for estrogen control. This page is educational harm-reduction reference compiled from peer-reviewed literature — not medical advice, not an endorsement, not a recommendation to use. Consult a licensed clinician before any decision.

IMPORTANT DISCLAIMER – NO DOCTOR-PATIENT RELATIONSHIP

Use of this Service, including any AI-generated responses, cycle recommendations, lab result analysis, risk assessments, or shared user content, does not create a doctor-patient, therapist-patient, or any other professional-client relationship. The information provided is for educational, informational, and harm-reduction purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment from a licensed physician. Never disregard professional medical advice or delay in seeking it because of something you have read or generated on this platform. If you have a medical emergency, call 911 (US) or your local emergency number immediately. Always consult your physician or other qualified healthcare provider with any questions regarding your health, medications, or cycle protocols. The operators of this platform are not licensed medical professionals and do not practice medicine.

Quick Facts

Class	Aromatase Inhibitors
Half-life	8.9 hours in men (Mauras 2003, PMID: 14671195); 27 hours is the postmenopausal-women figure on the FDA Aromasin label and remains in the engine PK block (pk.halfLifeHours) pending a separate golden-file review.
Elimination half-life (free hormone)	8.9 hours (healthy young males ages 14-26, 25mg PO daily x 10 days; Mauras et al. 2003 J Clin Endocrinol Metab, PMID: 14671195)
Detection window	5 days
Hepatotoxicity	Low
Suppression	0/10
Administration	oral
US regulatory status	fda-approved

Typical Dosing Ranges

Common dose range: On-cycle: 12.5mg EOD or 25mg E3D (community standard for AI-in-men). FDA-labelled adjuvant breast-cancer dose is 25mg/day — using daily in men on testosterone risks crashing estradiol.

Cycle length: As needed

Time to steady state: ~2 days

Clinical (FDA-labelled): 25mg once daily — FDA-labelled adjuvant breast-cancer dose for postmenopausal women. Daily dosing in men on testosterone over-suppresses estradiol.

On-cycle (community-reported): 12.5mg EOD or 25mg E3D — community-standard estradiol management on aromatizing cycles

Rescue / acute management: 12.5-25mg short-course for active gyno reversal; re-test E2 weekly and discontinue when symptoms resolve.

Exemestane is a steroidal suicide inhibitor — once a molecule binds aromatase, the enzyme is permanently inactive and the body must synthesize new enzyme (~3 day turnover). This is why exemestane has no rebound. Wave B.1.5 (2026-04-18) reconciled engine pk.halfLifeHours from 27h (postmenopausal-women figure on FDA Aromasin label) to 8.9h (men, Mauras 2003 PMID 14671195) — affects PCT timing math; see git history for golden-file diff review.

Dose ranges are compiled from published pharmacokinetic studies and community-reported usage. Where a value is community-reported rather than clinically studied, this page and its structured data flag it. Lower end of any range is always the safer starting point.

Stacking Considerations

No structural stacking blockers. Standard harm-reduction rules apply: minimize total androgen load, minimize oral exposure, and monitor bloodwork.

PCT Requirements

Depot clearance estimate: ~2 days post-last-dose before SERM start (5 × apparent depot half-life of 8.9h).
Never stack two SERMs. Extend a single SERM (tamoxifen OR enclomiphene/clomiphene) rather than combining.
Use the cycle planner to generate a full protocol based on your complete stack, not this compound alone.

Side Effect Profile

Easy to crash estradiol if used at the BC dose
Joint pain at therapeutic doses
Expensive
Must be taken with a fat-containing meal for absorption

Known Interactions

Exemestane (Aromasin) + Anastrozole (Arimidex)
moderate — pharmacokinetic
Stacking two AIs is unnecessary and risks estrogen crash.
Recommendation: Use only one AI. Switch, dont stack.
Monitor: Estradiol

Monitoring (Bloodwork & Vitals)

Comprehensive metabolic panel (baseline, mid-cycle, post-cycle)
Lipid panel (total cholesterol, HDL, LDL, triglycerides)
CBC (hemoglobin, hematocrit — watch for erythrocytosis)
Sex-hormone panel (Total T, Free T, Estradiol sensitive, SHBG, LH, FSH)
Blood pressure (weekly self-check; flag systolic >140 or diastolic >90)

Baseline bloodwork is recommended before any cycle. Discontinue if liver enzymes exceed 3× upper limit of normal or if hematocrit exceeds 54%.

Frequently Asked Questions

What is the half-life of Exemestane (Aromasin)?

Exemestane (Aromasin) has a half-life of approximately 8.9 hours in men (Mauras 2003, PMID: 14671195); 27 hours is the postmenopausal-women figure on the FDA Aromasin label and remains in the engine PK block (pk.halfLifeHours) pending a separate golden-file review.. Clearance estimate: 8.9h × 5 = 44.5h ≈ 1.85 days (Mauras 2003 PMID 14671195, men). The 27h figure on the FDA Aromasin label is the postmenopausal-women clinical PK package and is not appropriate for male PED-context cycle math.. This figure is used to determine injection frequency (for esters) and post-cycle clearance timing.

What is the typical dose range for Exemestane (Aromasin)?

Commonly reported ranges for Exemestane (Aromasin): On-cycle: 12.5mg EOD or 25mg E3D (community standard for AI-in-men). FDA-labelled adjuvant breast-cancer dose is 25mg/day — using daily in men on testosterone risks crashing estradiol.. Cycle length: As needed. These are compiled from published studies and community-reported usage — individual response varies and lower end is always preferred.

Does Exemestane (Aromasin) suppress natural testosterone?

Exemestane (Aromasin) causes minimal suppression of the HPTA axis (score 0/10). PCT may still be advisable depending on stack and duration.

Is Exemestane (Aromasin) liver toxic?

Hepatotoxicity rating: Low. Non-17αα compound — liver stress is lower but still warrants periodic monitoring during a cycle.

What is Exemestane (Aromasin) typically used for?

Exemestane (Aromasin) is commonly used for: On-cycle estradiol management when bloodwork confirms elevation, Preferred over anastrozole when no-rebound profile matters, All experience levels. Intended-use context does not imply safety — every use case carries the same underlying pharmacological risks.

Citations

Disclaimer

StackItSmart is an independent harm-reduction reference. The content above is compiled from peer-reviewed literature and is not medical advice, not an endorsement, and not a recommendation to use Exemestane (Aromasin). Performance-enhancing compounds carry legal, endocrine, cardiovascular, and hepatic risks. Consult a licensed clinician before any decision. StackItSmart does not provide sourcing, procurement, or dosing prescriptions.